Quadrant Capital Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Quadrant Capital Group's ANAB Position: Q2 2026 in Review
Quadrant Capital Group sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 177 shares — an estimated $9.82K sold.
Quadrant Capital Group first reported a position in ANAB in Q1 2020 and held it in 24 quarters. The position peaked at $21K in Q1 2020. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Quadrant Capital Group reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 177 AnaptysBio shares in Q2 2026, an estimated $9.82K.
- Quadrant Capital Group first reported a position in AnaptysBio in Q1 2020 and held it in 24 quarters.
- Quadrant Capital Group's AnaptysBio position peaked at $21K in Q1 2020.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.